Beryl Drugs Ltd vs Curis Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Beryl Drugs Ltd is ₹ 21 as of 06 May 15:30 . The P/E Ratio of Beryl Drugs Ltd changed from 14.1 on March 2021 to 18.5 on March 2025 . This represents a CAGR of 5.58% over 5 yearsThe P/E Ratio of Curis Lifesciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Beryl Drugs Ltd changed from ₹ 3.35 crore on March 2021 to ₹ 10.68 crore on March 2025 . This represents a CAGR of 26.10% over 5 yearsThe Market Cap of Curis Lifesciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Revenue of Beryl Drugs Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24 . The EBITDA of Beryl Drugs Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24 . The Net Profit of Beryl Drugs Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24 . The Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Curis Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Beryl Drugs Ltd

Beryl Drugs Limited was incorporated on August 24, 1993.
The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
It offers I.V. fluids, and a range of small and large volume injectables.
It provides a range of eye/ear drops, veterinary products, and injections.

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

FAQs for the comparison of Beryl Drugs Ltd and Curis Lifesciences Ltd

Which company has a larger market capitalization, Beryl Drugs Ltd or Curis Lifesciences Ltd?

Market cap of Beryl Drugs Ltd is 10 Cr while Market cap of Curis Lifesciences Ltd is 94 Cr

What are the key factors driving the stock performance of Beryl Drugs Ltd and Curis Lifesciences Ltd?

The stock performance of Beryl Drugs Ltd and Curis Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beryl Drugs Ltd and Curis Lifesciences Ltd?

As of May 6, 2026, the Beryl Drugs Ltd stock price is INR ₹21.0. On the other hand, Curis Lifesciences Ltd stock price is INR ₹116.5.

How do dividend payouts of Beryl Drugs Ltd and Curis Lifesciences Ltd compare?

To compare the dividend payouts of Beryl Drugs Ltd and Curis Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.